Parnell Pharmaceuticals Holdings (Parnell Pharmaceuticals Holdings) FCF Yield % : 0.00 (As of Jun. 06, 2024)

View and export this data going back to 2014. Start your Free Trial

What is Parnell Pharmaceuticals Holdings FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Parnell Pharmaceuticals Holdings's Trailing 12-Month Free Cash Flow is $-3.14 Mil, and Market Cap is $0.00 Mil. Therefore, Parnell Pharmaceuticals Holdings's FCF Yield % for today is 0.00%.

The historical rank and industry rank for Parnell Pharmaceuticals Holdings's FCF Yield % or its related term are showing as below:

PARNF's FCF Yield % is not ranked ^*
in the Drug Manufacturers industry.
Industry Median: -0.16
* Ranked among companies with meaningful FCF Yield % only.

Parnell Pharmaceuticals Holdings's FCF Margin % for the quarter that ended in Dec. 2018 was -16.48%.

Parnell Pharmaceuticals Holdings FCF Yield % Historical Data

The historical data trend for Parnell Pharmaceuticals Holdings's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Parnell Pharmaceuticals Holdings FCF Yield % Chart

Parnell Pharmaceuticals Holdings Annual Data

Trend

Jun12

Jun13

Jun14

Dec15

Dec16

Dec17

Dec18

FCF Yield %

Get a 7-Day Free Trial

-13.67

-36.51

-100.92

-30.81

-108.76

Parnell Pharmaceuticals Holdings Semi-Annual Data
	Jun12	Jun13	Jun14	Dec15	Dec16	Dec17	Dec18
FCF Yield %	Get a 7-Day Free Trial			-13.67	-36.51	-100.92	-30.81	-108.76

Competitive Comparison of Parnell Pharmaceuticals Holdings's FCF Yield %

For the Drug Manufacturers - Specialty & Generic subindustry, Parnell Pharmaceuticals Holdings's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Parnell Pharmaceuticals Holdings's FCF Yield % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Parnell Pharmaceuticals Holdings's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Parnell Pharmaceuticals Holdings's FCF Yield % falls into.

Parnell Pharmaceuticals Holdings FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Parnell Pharmaceuticals Holdings's FCF Yield % for the fiscal year that ended in Dec. 2018 is calculated as

FCF Yield %	=	Free Cash Flow	/	Market Cap
	=	-3.137	/	2.88432
	=	-108.76%

Parnell Pharmaceuticals Holdings's annualized FCF Yield % for the quarter that ended in Dec. 2018 is calculated as

FCF Yield %	=	Free Cash Flow	*	Annualized Factor	/	Market Cap
	=	-3.137	*	1	/	2.88432
	=	-108.76%

Parnell Pharmaceuticals Holdings FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.

Parnell Pharmaceuticals Holdings FCF Yield % Related Terms

Thank you for viewing the detailed overview of Parnell Pharmaceuticals Holdings's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

Parnell Pharmaceuticals Holdings (Parnell Pharmaceuticals Holdings) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Parnell Pharmaceuticals Holdings Ltd (OTCPK:PARNF) » Definitions » FCF Yield %

Comparable Companies

Traded in Other Exchanges

N/A

Address

476 Gardeners Road, Unit 4, Century Estate, Alexandria, Sydney, NSW, AUS, 2015

Website

https://www.parnell.com

Parnell Pharmaceuticals Holdings Ltd is an Australia based veterinary pharmaceutical company. It is focused on developing, manufacturing and commercializing animal health solutions. The group manufactures and market products for companion animals and production animals. The firm also has a pipeline of drug products like Zydax, PAR121 and PAR122 and Luminous which covers therapeutic areas in orthopedics, dermatology, and nutraceuticals. The operating segments of the company are Companion animal, Production animal - U.S., Production animal - rest of world and Contract Manufacturing. It operates internationally and generates the majority of the revenue from the Production animal - U.S. segment which covers the group's reproductive hormone portfolio across production animal in the USA.